Recombinant Thymidine Phosphorylase anticorps (full length)
Aperçu rapide pour Recombinant Thymidine Phosphorylase anticorps (full length) (ABIN7879143)
Antigène
Voir toutes Thymidine Phosphorylase (TYMP) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- full length
-
Fonction
- Recombinant PD-ECGF Antibody / Thymidine Phosphorylase (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogène
- Recombinant full-length human protein was used as the immunogen for the recombinant PD-ECGF antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant PD-ECGF antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the recombinant PD-ECGF antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Thymidine Phosphorylase (TYMP)
-
Autre désignation
- PD-ECGF
-
Sujet
- Recognizes a protein (amino acid 482) of 55 kDa (in vivo 110 kDa homodimer), identified as platelet-derived endothelial growth factor (PD-ECGF), same as thymidine phosphorylase (TP) or gliostatin. In the presence of inorganic orthophosphate, it catalyzes the reversible phospholytic cleavage of thymidine and deoxyuridine to their corresponding bases and 2-deoxyribose-1-phosphate. It is both chemotactic and mitogenic for endothelial cells and a non-heparin binding angiogenic factor present in platelets. Its enzymatic activity is crucial for angiogenic activity (metabolite is angiogenic). Higher levels of serum TP/PD-ECGF are observed in cancer patients. It is also involved in transformation of fluoropyrimidines, cytotoxic agents used in the treatment of a variety of malignancies, into active cytotoxic metabolites (e.g. 5-deoxy-5-fluorouridine to 5-FU). High intra-cellular levels of TP/PD-ECGF are associated with increased chemosensitivity to such antimetabolites.
-
UniProt
- P19971
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Antigène
-